Get the Stockscreener App
20.30
8.13%
1.66
Direxion Daily Pharmaceutical Medical Bull 3 X Etf stock is traded at $20.30, with a volume of 70,569.
It is up +8.13% in the last 24 hours and up +73.75% over the past month.
See More
Previous Close:
$18.64
Open:
$19.82
24h Volume:
70,569
Relative Volume:
1.05
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+11.60%
1M Performance:
+73.75%
6M Performance:
+58.95%
1Y Performance:
+280.28%
1-Day Range:
$19.80
$20.41
1-Week Range:
$17.11
$20.41
52-Week Range:
$5.20
$20.41
Direxion Daily Pharmaceutical Medical Bull 3 X Etf Stock (PILL) Company Profile
Name
Direxion Daily Pharmaceutical Medical Bull 3 X Etf
Sector
Industry
Phone
-
Address
-
Compare PILL vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PILL
Direxion Daily Pharmaceutical Medical Bull 3 X Etf
|
20.31 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.27 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
746.62 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
750.06 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
299.03 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
706.94 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Pharmaceutical Medical Bull 3 X Etf Stock (PILL) Latest News
(PILL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Direxion Daily Pharmaceutical & Medical Bull 3X Shares declares quarterly distribution of $0.0152 - MSN
Direxion Daily Healthcare Bull 3X Shares declares quarterly distribution of $0.3746 - MSN
Rhythm Pharmaceuticals Inc (RYTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
When Pills Fail: Texas Family Physician Dr. Janet Hurley Exposes the Unseen Spiritual Battle Sabotaging Modern Healthcare - Barchart.com
Disc Medicine Inc (IRON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apellis Pharmaceuticals Inc (APLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Agios Pharmaceuticals Inc (AGIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
(PILL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
BioCryst Pharmaceuticals Inc (BCRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Small Cell Lung Cancer Pipeline Shows Strong Momentum as 100+ Pharma Companies in the Race | DelveInsight - Barchart.com
Top Performing Leveraged/Inverse ETFs: 06/14/2026 - ETF Database
Generalized Anxiety Disorder Market: Growth Momentum Across 7MM to 2036 – DelveInsight | VistaGen Therapeutics, Fabre-Kramer Pharm, Mind Med, Sunovion, ChemRar Research, Biohaven Pharma, Forest Lab - Barchart.com
They're Heeere: Leveraged Cybersecurity ETFs - Yahoo Finance
IgA Nephropathy Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com
Houston vs Los Angeles A: Total Runs - Coinbase
Unique Verve Named Boston’s Top-Rated Functional Medicine & Skincare Practice 22-Year Award-Winning Practice – Recognized by Allure, InStyle & Boston Magazine – Earns Perfect 5-Star Rating - Barchart.com
Dr. Eric Haeger Launches National Scholarship to Support the Next Generation of Medical Professionals - Barchart.com
Alpha Thalassemia Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Forma Therapeutics, Genmedicn Biopharma, Bristol-Myers Squibb, Agios Pharma - Barchart.com
Here's Why the Direxion Daily Semiconductor Bull 3X ETF Soared Today (Hint: It's Alphabet and Intel Related) - Yahoo Finance
(PILL) Risk Channels and Responsive Allocation - Stock Traders Daily
Gastroparesis Market Shows Strong Future Potential with Increasing Industry Investments by 2036 – DelveInsight | Vanda Pharma, Dr. Falk Pharma GmbH, Alfasigma S.p.A., PTC Therapeutics, CinDome Pharma - Barchart.com
Osteoarthritis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2036 – DelveInsight | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharma - Barchart.com
5 Biggest Biotechnology ETFs in 2026 - Investing News Network
SOXL: How Disciplined Tactical Moves In And Out Could Compound Wealth Over 30 Years - Seeking Alpha
Excessive Daytime Sleepiness Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Avadel Pharma, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma - Barchart.com
How Is Union Pacific’s Stock Performance Compared to Other Transportation Stocks? - Barchart.com
CPKC to maintain rail operations across Canada during IBEW strike - Barchart.com
These 3 Software Stocks Are Buying Back Shares Hand Over Fist - Barchart.com
Trump ponders whether to move forward with Iran deal but hasn't yet decided - Barchart.com
Why Are Atlassian (TEAM) Shares Soaring Today - Barchart.com
CrowdStrike and Palo Alto Networks Shares Are Soaring, What You Need To Know - Barchart.com
PagerDuty (PD) Stock Trades Up, Here Is Why - Barchart.com
HVAC in Data Center Market to Reach USD 31.80 Billion by 2032 Driven by AI Workloads and Hyperscale Data Center Expansion - Barchart.com
Fears of a Poor India Monsoon Lift Sugar Prices - Barchart.com
The 180-Day Lease Holding Up SpaceX's $2 Trillion IPO - Barchart.com
A $6 Billion Reason Snowflake Stock Is Up Today - Barchart.com
VERI UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Veritone (VERI) Investors of Securities Class Action Deadline on July 20, 2026 - Barchart.com
How Is Adobe's Stock Performance Compared to Other Tech-Software Stocks? - Barchart.com
Marvell’s Q1 Earnings Strengthen Its Bull Case — But MRVL Stock Isn’t a Screaming Buy Yet - Barchart.com
Eshbal Announces Appointment of Nir Peles to Board of Directors, Achievement of Revenue Milestones and Ontario Continuance - Barchart.com
Hog Traders Looking to Friday Trade - Barchart.com
Indonesians mark 20 years since mud volcano eruption swallowed up entire communities in East Java - Barchart
2 Services Stocks with Impressive Fundamentals and 1 We Avoid - Barchart.com
3 Reasons IP is Risky and 1 Stock to Buy Instead - Barchart.com
France’s parliament votes to repeal slavery-era Black Code, with tears and history in the chamber - Barchart.com
Caesars Entertainment, a Las Vegas Strip icon, is sold for nearly $6 billion - Barchart.com
Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - Barchart.com
Apex Trader Funding Launches Massive 90% Off Promotion, New 5-Pack Bundles, and Zero Activation Fee Options for Futures Traders - Barchart.com
Zelenskyy says he's pressing US for more Patriot missiles for Ukraine to counter Russian strikes - Barchart.com
Direxion Daily Pharmaceutical Medical Bull 3 X Etf Stock (PILL) Financials Data
There is no financial data for Direxion Daily Pharmaceutical Medical Bull 3 X Etf (PILL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.19%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):